Pathstone Family Office’s Evolv Technologies EVLV Stock Holding History
Bought
Maintained
Sold
Other funds holding EVLV
GCGM
DCI
ECG
GCM
GIPM
SM
Pathstone Family Office's EVLV Position: Q3 2023 in Review
Pathstone Family Office increased its Evolv Technologies (EVLV) stake by 16% in Q3 2023, buying an estimated $50K and bringing the position to 59,527 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.
Pathstone Family Office first reported a position in EVLV in Q3 2021 and has held it in 9 quarters since. The position peaked at $562K in Q3 2022. 175 funds tracked by Wall St. Rank hold EVLV as of Q3 2023.
- Pathstone Family Office held 59,527 shares of Evolv Technologies worth $289K as of Q3 2023.
- Pathstone Family Office bought 8,118 Evolv Technologies shares in Q3 2023, an estimated $50K.
- Evolv Technologies made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1333 holding.
- Pathstone Family Office first reported a position in Evolv Technologies in Q3 2021 and has held it in 9 quarters since.
- Pathstone Family Office's Evolv Technologies position peaked at $562K in Q3 2022.
- 175 funds tracked by Wall St. Rank held Evolv Technologies as of Q3 2023.
Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.